Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)
Completed · Phase 1/Phase 2
Conditions studied: Alcohol Dependence, Drug Dependence
In brief
The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
Key facts
- Study ID
- NCT00183118
- Run by
- Boston Medical Center
- People needed
- 180
- Starts
- 2004-10-01
- Expected to finish
- 2005-12-01
- Last updated by the study team
- 2017-07-21
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18-70 years old;
- In-patient at LRCA (i.e., primary diagnosis of alcohol or drug dependence);
- Abstinence from alcohol and other substances of abuse for 4 days;
- Willingness to undergo HIV testing as per standard narcology hospital counseling and testing protocol or known positive HIV serostatus;
- Provision of contact information (e.g., name, home address, telephone number) of two relatives or close friends who can be contacted to share information that may be used to assist with follow-up;
- Stable address within St. Petersburg or districts within 100 kilometers of St. Petersburg; and
- Self-reported unprotected anal or vaginal sex in the last 6 months;
You may not qualify if…
- Not fluent in Russian;
- Severe cognitive impairment (Clinically apparent dementia, active psychosis, or severe paranoid disorder) as judged by a narcology hospital clinician and stated in the records;
- Inability to provide informed consent;
- Suspected or diagnosed pulmonary tuberculosis, not receiving treatment;
- Pending legal charges with potential impending incarceration.
Where it is running
- Boston Medical Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.